Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBLITUXIMAB for Relapsing multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where UBLITUXIMAB was used for Relapsing multiple sclerosis.

Most Reported Side Effects for UBLITUXIMAB

Side Effect Reports % Deaths Hosp.
Infusion related reaction 538 34.0% 0 21
Fatigue 110 7.0% 1 9
Headache 55 3.5% 1 5
Inappropriate schedule of product administration 53 3.4% 1 0
Malaise 49 3.1% 0 3
Multiple sclerosis relapse 48 3.0% 1 18
Asthenia 45 2.8% 0 7
Pain 45 2.8% 0 5
Illness 43 2.7% 0 4
Urinary tract infection 42 2.7% 2 13
Covid-19 39 2.5% 1 11
Gait disturbance 37 2.3% 0 5
Nasopharyngitis 37 2.3% 1 3
Nausea 37 2.3% 1 4
Pain in extremity 37 2.3% 1 7

Other Indications for UBLITUXIMAB

Multiple sclerosis (1,455) Chronic lymphocytic leukaemia (62) Non-hodgkin's lymphoma (17) Product used for unknown indication (12) B-cell lymphoma (7) Follicular lymphoma (5)

Other Drugs Used for Relapsing multiple sclerosis

OCRELIZUMAB (6,883) OFATUMUMAB (3,705) FINGOLIMOD (851) GLATIRAMER (375) ALEMTUZUMAB (350) SIPONIMOD (194) INTERFERON BETA-1A (192) NATALIZUMAB (140) RITUXIMAB (136) OZANIMOD (127)

Related Pages

UBLITUXIMAB Full Profile All Relapsing multiple sclerosis Drugs UBLITUXIMAB Demographics UBLITUXIMAB Timeline